Literature DB >> 16285017

Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.

Iris Meisen1, Alexander W Friedrich, Helge Karch, Ute Witting, Jasna Peter-Katalinić, Johannes Müthing.   

Abstract

Shiga toxin 1 (Stx1) represents an AB5 toxin produced by enterohemorrhagic Escherichia coli, which cause gastrointestinal diseases in humans that are often followed by potentially fatal systemic complications, such as acute encephalopathy and hemolytic uremic syndrome. The expression of the preferential Stx1 receptor, Gb3Cer/CD77 (Gal alpha1-4Gal beta1-4Glc beta1-1Cer), is one of the primary determinants of susceptibility to tissue injury. Due to the clinical importance of this life-threatening toxin, a combined strategy of preparative high-performance thin-layer chromatography (HPTLC) overlay assay and mass spectrometry was developed for the detection and structural characterization of Stx1-binding glycosphingolipids (GSLs). A preparation of neutral GSLs from human erythrocytes, comprising 21.4% and 59.1% of the high- and low-affinity Stx1-binding ligands Gb3Cer/CD77 and Gb4Cer, respectively, was separated on silica gel precoated HPTLC plates and probed for the presence of Stx1 receptors. Stx1 positive on the one hand and anti-Gb3Cer/CD77 and anti-Gb4Cer antibody positive bands from parallel reference runs on the other hand were extracted with chloroform/methanol/water (30/60/8, v/v/v). These crude extracts were used without any further purification for a detailed structural analysis by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry (nanoESI-QTOF-MS) in the negative ion mode. In all extracts investigated, neutral GSLs were detected as singly charged deprotonated molecular ions, [M-H]-, and neither buffer-derived salt adducts nor coextracted contaminants from the overlay assay procedure or the silica gel layer were observed. For the structural characterization of Stx1- and antibody-binding GSLs low-energy collision-induced dissociation (CID) was applied to high and low abundant receptor species of the crude extracts. All MS/MS spectra obtained contained full series of Y-type ions, B-type ions and additional ions generated by ring cleavages of the sugar moiety. Only analytical quantities in the microgram scale of a single GSL species within the complex GSL mixture were required for the structural MS characterization of Stx1 ligands as Gb3Cer/CD77 and Gb4Cer. This effective combined HPTLC/MS procedure offers a broad range of applications, not only for toxins of bacterial origin, but also for any GSL-binding agents such as plant-derived lectins or human proteins with yet unknown binding specificities. 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285017     DOI: 10.1002/rcm.2241

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  17 in total

1.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.

Authors:  Christian H Schweppe; Petra Hoffmann; Jerzy-Roch Nofer; Gottfried Pohlentz; Michael Mormann; Helge Karch; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

2.  Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.

Authors:  Daniel Steil; Catherine-Louise Schepers; Gottfried Pohlentz; Nadine Legros; Jana Runde; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2015-10-13       Impact factor: 5.922

3.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.

Authors:  Josefine Betz; Martina Bielaszewska; Andrea Thies; Hans-Ulrich Humpf; Klaus Dreisewerd; Helge Karch; Kwang S Kim; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

Review 4.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

5.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

6.  New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants.

Authors:  Wenlan Zhang; Martina Bielaszewska; Matthias Pulz; Karsten Becker; Alexander W Friedrich; Helge Karch; Thorsten Kuczius
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

7.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.

Authors:  Christian H Schweppe; Martina Bielaszewska; Gottfried Pohlentz; Alexander W Friedrich; Heino Büntemeyer; M Alexander Schmidt; Kwang S Kim; Jasna Peter-Katalinić; Helge Karch; Johannes Müthing
Journal:  Glycoconj J       Date:  2008-01-05       Impact factor: 2.916

8.  Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.

Authors:  Nadine Legros; Gottfried Pohlentz; Daniel Steil; Ivan U Kouzel; Ivan Liashkovich; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2018-06-04       Impact factor: 5.922

9.  Lipidomics of glycosphingolipids.

Authors:  Hany Farwanah; Thomas Kolter
Journal:  Metabolites       Date:  2012-02-02

10.  Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer.

Authors:  Ute Distler; Jamal Souady; Marcel Hülsewig; Irena Drmić-Hofman; Jörg Haier; Alexander W Friedrich; Helge Karch; Norbert Senninger; Klaus Dreisewerd; Stefan Berkenkamp; M Alexander Schmidt; Jasna Peter-Katalinić; Johannes Müthing
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.